• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】YM-53389

【化学名称】(+)-2-Chloro-5-methoxy-4-[5-[piperidin-2(S)-ylmethyl]-1,2,4-oxadiazol-3-yl]phenylamine monohydrochloride

【CA登记号】220850-98-6, 220850-99-7 ((R)-isomer), 174822-16-3 (free base, undefined isomer)

【 分 子 式 】C15H20Cl2N4O2

【 分 子 量 】359.25825

【开发单位】Yamanouchi (Originator)

【药理作用】Constipation, Agents for, Gastric Emptying Disorders,Treatment of of, GASTROINTESTINAL DRUGS, Prokinetic Agents, 5-HT4 Agonists

合成路线1

Benzamide (II) was prepared by treatment of the benzotriazolyl ester (I) with ammonium hydroxide in DMF. Dehydration of amide (II) with phosphorus oxychloride gave rise to nitrile (III), and subsequent addition of hydroxylamine to the cyano group of (III) furnished the N-hydroxybenzamidine (IV). Cyclization of (IV) with methyl 2-piperidineacetate (V) in the presence of NaH produced the oxadiazole compound (VI). Racemic (VI) was resolved employing L-ditoluoyltartaric acid, and the desired (S)-enantiomer was finally converted to the corresponding hydrochloride salt.

1 Suzuki, T.; Iwaoka, K.; Imanishi, N.; Nagakura, Y.; Miyata, K.; Nakahara, H.; Ohta, M.; Mase, T.; Synthesis of the selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist (+)-(S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-yl]aniline. Chem Pharm Bull 1999, 47, 1, 120.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18543 4-[(1H-1,2,3-benzotriazol-1-yloxy)carbonyl]-2-chloro-5-methoxyphenylamine; 4-[(1H-1,2,3-benzotriazol-1-yloxy)carbonyl]-2-chloro-5-methoxyaniline C14H11ClN4O3 详情 详情
(II) 51327 4-amino-5-chloro-2-methoxybenzamide C8H9ClN2O2 详情 详情
(III) 51328 4-amino-5-chloro-2-methoxybenzonitrile C8H7ClN2O 详情 详情
(IV) 51329 4-amino-5-chloro-N'-hydroxy-2-methoxybenzenecarboximidamide C8H10ClN3O2 详情 详情
(V) 40753 methyl 2-(2-piperidinyl)acetate C8H15NO2 详情 详情
(VI) 51330 2-chloro-5-methoxy-4-[5-(2-piperidinylmethyl)-1,2,4-oxadiazol-3-yl]aniline; 2-chloro-5-methoxy-4-[5-(2-piperidinylmethyl)-1,2,4-oxadiazol-3-yl]phenylamine C15H19ClN4O2 详情 详情
Extended Information